Clinical Trial Update: Intravesical BCG Administration to Patients With Invasive Bladder Cancer [NA]

View source ↗

Summary

Clinical trial update on intravesical BCG administration for invasive bladder cancer; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin) intravesical (Bacillus Calmette-Guérin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Bladder Cancer | NA | Status: TERMINATED | Results posted: 2019-11-05